Advertisement
Advertisement
U.S. markets open in 7 hours 6 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Eli Lilly and Company (LILY34.SA)

São Paulo - São Paulo Delayed Price. Currency in BRL
58.08-0.11 (-0.19%)
At close: 04:53PM BRT
Advertisement
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close58.19
Open0.00
Bid53.00 x 0
Ask59.19 x 0
Day's Range0.00 - 0.00
52 Week Range
Volume0
Avg. Volume9,360
Market Cap1.659T
Beta (5Y Monthly)0.35
PE Ratio (TTM)48.40
EPS (TTM)1.20
Earnings DateN/A
Forward Dividend & Yield0.70 (1.21%)
Ex-Dividend DateFeb 14, 2023
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for LILY34.SA

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Insider Monkey

      15 Most Promising Long-Term Stocks According to Analysts

      In this article, we will take a look at the 15 most promising long-term stocks according to analysts. To see more such companies, go directly to 5 Most Promising Long-Term Stocks According to Analysts. Investing in the stock market for the long term is perhaps the surest of the ways to expand your wealth. On […]

    • Simply Wall St.

      Estimating The Intrinsic Value Of Eli Lilly and Company (NYSE:LLY)

      Key Insights The projected fair value for Eli Lilly is US$388 based on 2 Stage Free Cash Flow to Equity With US$329...

    • Motley Fool

      Bernie Sanders Wants to Cap Insulin Prices at $20 per Vial

      Bernie Sanders recently introduced legislation to make insulin more affordable for people with diabetes. Senator Bernie Sanders, the Senate Health, Education, Labor, and Pensions Committee chairman, and Congresswoman Cori Bush recently introduced legislation to make insulin affordable for more Americans, so no one has to ration their insulin due to financial concerns. In a March 9, 2023 press release, Sen. Sanders said, "There is no reason why Americans should pay the highest prices in the world for insulin -- in some cases, 10 times as much as people in other countries."

    Advertisement
    Advertisement